
Globe Life
GL · NYSE · Insurance
Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time
- Market cap
- $12,1 bn
- Div. yield
- 0,7%
- Year to date
- +14,5%
Ratio score
based on 7 metrics as of 16.11.2026 ·
Verdict by our methodology based on current metrics. Not an investment recommendation.
Key metrics
3 ✓ · 4 — · 0 ✕ · 3 n/a · hover over a row or tap it to see the trend
All metrics
| Metric | Value | 5-year median | Industry median |
|---|---|---|---|
| P/E TTM | 10,2 | 11,0 | 12,9 |
| Forward P/E | 9,8 | — | 12,6 |
| PEG | 1,3 | — | 1,6 |
| P/S | 1,9 | 1,9 | 1,9 |
| EV/EBITDA | 9,3 | 9,9 | 11,0 |
| P/FCF | 9,1 | — | 9,2 |
| P/B | 1,8 | 2,0 | 2,0 |
Industry median — across 22 profitable companies in “Insurance” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.
Price chart
Compare with
Choose a stock
Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.
Analysts
Ratings, 23 analysts
- Buy
- 15
- Hold
- 8
- Sell
- 0
Beat the EPS forecast in 0 of the last 4 quarters
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | 5,03 | 4,84 | Down −3,7% |
| Q2 2026 | 3,79 | 3,61 | Down −4,7% |
| Q1 2026 | 3,58 | 3,43 | Down −4,1% |
| Q4 2025 | 3,54 | 3,39 | Down −4,2% |
Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.
Financials in charts
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,60 bn | 1,60 bn | 1,56 bn | 1,52 bn | 1,51 bn | 1,48 bn | 1,48 bn | 1,47 bn | 1,46 bn | 1,44 bn | 1,42 bn | 1,42 bn |
| EPS | 4,62 | 3,65 | 3,39 | 3,30 | 4,73 | 3,05 | 3,01 | 3,01 | 3,44 | 2,83 | 2,67 | 2,88 |
| Margin | 22,6% | 18,0% | 17,3% | 17,5% | 25,6% | 17,1% | 17,2% | 17,4% | 20,8% | 17,9% | 18,0% | 19,4% |
| FCF | 311 m | 298 m | 396 m | 330 m | 209 m | 295 m | 420 m | 322 m | 311 m | 356 m | 342 m | 378 m |
From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.
Owners
Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.
Insider trades over 12 months
Over 12 months: no purchases, sales $82,7 m.
| Name | Amount | Shares | Price |
|---|---|---|---|
| zorn rebecca e11 Nov 2026 · sale | $161 530 | 1 000 | $161,53 |
| majors michael clay23 Oct 2026 · sale | $2,22 m | 14 377 | $154,48 |
| hensley robert edward22 Sep 2026 · sale | $1,13 m | 6 656 | $170,34 |
| hensley robert edward22 Sep 2026 · sale | $566 912 | 3 344 | $169,53 |
| mitchell robert brian7 Aug 2026 · sale | $187 892 | 1 017 | $184,75 |
| mitchell robert brian7 Aug 2026 · sale | $1,94 m | 10 529 | $183,83 |
| mitchell robert brian7 Aug 2026 · sale | $2,09 m | 11 454 | $182,77 |
| darden james matthew31 Jul 2026 · sale | $73 343 | 400 | $183,36 |
| darden james matthew31 Jul 2026 · sale | $9,05 m | 49 600 | $182,43 |
| kalmbach thomas peter30 Jul 2026 · sale | $507 264 | 2 790 | $181,81 |
| kalmbach thomas peter30 Jul 2026 · sale | $480 255 | 2 650 | $181,23 |
| kalmbach thomas peter30 Jul 2026 · sale | $871 578 | 4 840 | $180,08 |
| kalmbach thomas peter30 Jul 2026 · sale | $1,92 m | 10 720 | $179,30 |
| majors michael clay29 Jul 2026 · sale | $627 722 | 3 500 | $179,35 |
| majors michael clay29 Jul 2026 · sale | $5,98 m | 33 500 | $178,56 |
SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.
About the company
- Industry
- Insurance
- Exchange
- NYSE
- Country
- US
- IPO date
- 31 Dec 1980
- Website
- home.globelifeinsurance.com
Company description, revenue by segment and region, and the CEO will come later.
Earnings
- Next report
- date not announced
An AI summary of the earnings call will come later.
Peers
| Company | Price | ||||
|---|---|---|---|---|---|
ERIEErie Indemnity | $275,91 | no score | 22,2 | +2,0% | 14,0% |
AIZAssurant | $323,80 | 71★★★★★★★★★would consider | 14,7 | +9,4% | 7,8% |
EGEverest Group | $433,00 | 79★★★★★★★★★would consider | 8,4 | −8,7% | 11,7% |
LLoews Corporation | $111,84 | 50★★★★★★★★would watch | 15,2 | +2,8% | 7,9% |
BROBrown & Brown | $73,51 | 57★★★★★★★★would watch | 19,6 | +26,1% | 17,6% |
Ratio — a score by our methodology, not an investment recommendation.




